|
Jul 17
|
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
|
|
Jul 16
|
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum?
|
|
Jul 16
|
Synopsys (SNPS) Moves 3.6% Higher: Will This Strength Last?
|
|
Jul 9
|
Best Growth Stocks to Buy for July 9th
|
|
Jun 25
|
Best Growth Stocks to Buy for June 25th
|
|
Jun 24
|
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
|
|
May 22
|
Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain?
|
|
May 13
|
OptimizeRx Corp (OPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts
|
|
May 12
|
OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates
|
|
May 12
|
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
|
|
May 1
|
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
|
|
Mar 13
|
OptimizeRx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Mar 13
|
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion
|
|
Mar 13
|
Q4 2024 OptimizeRx Corp Earnings Call
|
|
Mar 12
|
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
|
|
Mar 12
|
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
|
|
Mar 11
|
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
|
|
Mar 10
|
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
|
|
Jan 2
|
Is There An Opportunity With OptimizeRx Corporation's (NASDAQ:OPRX) 49% Undervaluation?
|
|
Oct 3
|
OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last?
|